Los Angeles Capital Management LLC Agenus Inc Transaction History

Los Angeles Capital Management LLC

$24.7 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 05, 2024	SELL	$0.53 - $0.93 $13,536 - $23,752	-25,540 Reduced 12.72%	175,272 $101,000
Q4 2023 Feb 06, 2024	BUY	$0.63 - $1.14 $61,734 - $111,710	97,992 Added 95.3%	200,812 $166,000
Q3 2023 Nov 06, 2023	SELL	$1.12 - $1.88 $311,908 - $523,561	-278,490 Reduced 73.04%	102,820 $116,000
Q2 2023 Aug 03, 2023	BUY	$1.31 - $2.04 $27,282 - $42,485	20,826 Added 5.78%	381,310 $610,000
Q1 2023 May 04, 2023	SELL	$1.45 - $2.95 $207,948 - $423,068	-143,413 Reduced 28.46%	360,484 $547,000
Q4 2022 Feb 06, 2023	SELL	$2.02 - $3.25 $1.19 Million - $1.91 Million	-588,321 Reduced 53.86%	503,897 $1.21 Million
Q3 2022 Nov 02, 2022	BUY	$1.96 - $3.14 $522,275 - $836,706	266,467 Added 32.27%	1,092,218 $2.24 Million
Q2 2022 Aug 05, 2022	BUY	$1.3 - $2.64 $985,871 - $2 Million	758,363 Added 1125.37%	825,751 $1.6 Million
Q4 2021 Feb 03, 2022	SELL	$2.92 - $5.74 $2,000 - $3,931	-685 Reduced 1.01%	67,388 $217,000
Q3 2021 Nov 08, 2021	SELL	$4.98 - $6.63 $1.19 Million - $1.58 Million	-238,798 Reduced 77.82%	68,073 $357,000
Q2 2021 Aug 05, 2021	SELL	$2.56 - $5.49 $631,994 - $1.36 Million	-246,873 Reduced 44.58%	306,871 $1.69 Million
Q1 2021 May 05, 2021	SELL	$2.69 - $5.25 $277,648 - $541,878	-103,215 Reduced 15.71%	553,744 $1.51 Million
Q4 2020 Feb 04, 2021	BUY	$3.17 - $4.49 $906,857 - $1.28 Million	286,075 Added 77.13%	656,959 $2.09 Million
Q3 2020 Nov 02, 2020	SELL	$2.98 - $5.2 $313,040 - $546,244	-105,047 Reduced 22.07%	370,884 $1.48 Million
Q2 2020 Aug 05, 2020	BUY	$2.29 - $4.24 $1.09 Million - $2.02 Million	475,931 New	475,931 $1.87 Million

Others Institutions Holding AGEN

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

View Full List

About AGENUS INC

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

More about AGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.

Account